Aurora Daljit Singh — SEC Form 4 filings
SEC reporting owner CIK 1793971. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-21.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-16 to 2026-08-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 5 filings — 583,266 shares, $1,044,930 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 74.
- Largest priced transaction: sale of 114,703 shares @ $2.68 ($307,026) in Neumora Therapeutics, Inc., filed 2025-11-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | See Remarks | 11 | — | 14 legs · 583,266 sh · $1,044,930 | 74 |
Form 4 filings — Aurora Daljit Singh
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Neumora Therapeutics, Inc. (NMRA) | Option exercise (M): 67,741 @ $0.72 · Sale (S): 67,741 @ $1.51 · Option exercise (M): 21,685 @ $0.72 · Option exercise (M): 45,026 @ $0.72 · Sale (S): 66,711 @ $1.51 · Option exercise (M): 20,553 @ $0.72 · +9 more | EDGAR |
| 2026-08-19 | 4 | Neumora Therapeutics, Inc. (NMRA) | Option exercise (M): 40,890 @ $0.72 · Option exercise (M): 15,355 @ $0.72 · Option exercise (M): 1,424 @ $0.72 · Option exercise (M): 1 @ $0.72 · Sale (S): 57,670 @ $1.51 · Sale (S): 34,020 @ $1.49 · +23 more | EDGAR |
| 2026-02-19 | 4 | Neumora Therapeutics, Inc. (NMRA) | Sale (S): 6,165 @ $3.56 | EDGAR |
| 2026-01-09 | 4 | Neumora Therapeutics, Inc. (NMRA) | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Neumora Therapeutics, Inc. (NMRA) | Sale (S): 114,703 @ $2.68 | EDGAR |
| 2025-05-30 | 4 | Neumora Therapeutics, Inc. (NMRA) | Disposition to issuer (D): 40,890 (derivative) · Disposition to issuer (D): 137,538 (derivative) · Disposition to issuer (D): 207,901 (derivative) · Disposition to issuer (D): 136,210 (derivative) · Disposition to issuer (D): 72,221 (derivative) · Disposition to issuer (D): 29,737 (derivative) · +10 more | EDGAR |
| 2025-02-20 | 4 | Neumora Therapeutics, Inc. (NMRA) | Sale (S): 8,565 @ $1.68 | EDGAR |
| 2025-02-18 | 4 | Neumora Therapeutics, Inc. (NMRA) | Grant/award (A): 1,000,000 (derivative) @ $0 · Disposition to issuer (D): 40,890 (derivative) · Disposition to issuer (D): 137,538 (derivative) · Disposition to issuer (D): 207,901 (derivative) · Disposition to issuer (D): 136,210 (derivative) · Disposition to issuer (D): 72,221 (derivative) · +9 more | EDGAR |
| 2024-09-13 | 4 | Neumora Therapeutics, Inc. (NMRA) | Gift (G): 137,538 (derivative) @ $0 · Gift (G): 137,538 (derivative) @ $0 · Gift (G): 136,210 (derivative) @ $0 · Gift (G): 136,210 (derivative) @ $0 · Gift (G): 29,737 (derivative) @ $0 · Gift (G): 29,737 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4 | Neumora Therapeutics, Inc. (NMRA) | Gift (G): 114,703 @ $0 | EDGAR |
| 2024-02-16 | 4 | Neumora Therapeutics, Inc. (NMRA) | Grant/award (A): 97,500 @ $0 · Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1793971 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →